Taysha Gene Therapies
TSHA
#5714
Rank
NZ$2.37 B
Marketcap
NZ$7.28
Share price
-1.48%
Change (1 day)
-0.02%
Change (1 year)

P/S ratio for Taysha Gene Therapies (TSHA)

P/S ratio as of November 2026 (TTM): 238

According to Taysha Gene Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.37. At the end of 2023 the company had a P/S ratio of 21.4.

P/S ratio history for Taysha Gene Therapies from 2020 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202321.4-62.03%
202256.4
2021N/A
2020N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA